title: Tacrolimus therapy for refractory acute renal allograft rejection: a 4-year experience with an aggressive approach.
authors.affiliation: Department of Surgery, University of Chicago, Illinois, USA.
authors.forename: C D
authors.initials: CD
authors.lastname: Turner
authors.forename: D S
authors.initials: DS
authors.lastname: Bruce
authors.forename: D C
authors.initials: DC
authors.lastname: Cronin
authors.forename: G E
authors.initials: GE
authors.lastname: Loss
authors.forename: H
authors.initials: H
authors.lastname: Grewal
authors.forename: C
authors.initials: C
authors.lastname: Siegel
authors.forename: J M
authors.initials: JM
authors.lastname: Millis
authors.forename: K A
authors.initials: KA
authors.lastname: Newell
authors.forename: B
authors.initials: B
authors.lastname: Davis
authors.forename: T
authors.initials: T
authors.lastname: Todo
authors.forename: J R
authors.initials: JR
authors.lastname: Thistlethwaite
authors.forename: E S
authors.initials: ES
authors.lastname: Woodle
mesh_terms: D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000368:Aged; D001379:Azathioprine / Q000627:therapeutic use; D001707:Biopsy, Needle; D016572:Cyclosporine / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D006085:Graft Survival; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology* / Q000401:mortality / Q000473:pathology; D008297:Male; D008875:Middle Aged; D016853:Muromonab-CD3 / Q000627:therapeutic use; D015996:Survival Rate; D016559:Tacrolimus / Q000627:therapeutic use*
chemical_list: D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; D016572:Cyclosporine; D001379:Azathioprine; D016559:Tacrolimus